Description

BETH ISRAEL DEACONESS MEDICAL CENTER, HARVARD MEDICAL SCHOOL, BOSTON MA – is seeking faculty members, especially those with interests in drug allergies and desensitization, at the Instructor or Assistant Professor level to participate in the clinical, teaching and research academic activities of the Division of Allergy and Inflammation, Department of Medicine. As we expand our consultative services to the Dana Farber Cancer Institute, we are specifically seeking candidates with expertise in drug hypersensitivity to provide state of the art onco-allergy care as a member of the multidisciplinary chemotherapy desensitization team. This role includes general Adult Allergy/Immunology clinic sessions.  Applicants should be board eligible/certified in allergy and will be eligible for academic appointments at Harvard Medical School. Positions are available currently. 

Please submit letters of interest along with a CV to: Peter F. Weller, MD, Chair, Search Committee, Beth Israel Deaconess Medical Center,110 Francis Street, Boston, MA 02215 or to: scerisie@bidmc.harvard.edu.

 The Beth Israel Deaconess Medical Center (BIDMC) and Harvard Medical School are equal opportunity employers; and all qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, disability status, protected veteran status, gender identity, sexual orientation, pregnancy and pregnancy-related conditions or any other characteristic protected by law. Women and minorities are strongly encouraged to apply.

 As a teaching hospital of Harvard Medical School, BIDMC and the Department of Medicine, provide a clinically advanced and supportive academic environment for residents, fellows, and faculty. We’re also proud and excited to be an integral part of the landmark collaboration among Dana-Farber Cancer Institute (DFCI), Beth Israel Deaconess Medical Center (BIDMC), and Harvard Medical Faculty Physicians (HMFP) to establish New England’s only freestanding adult inpatient cancer hospital. The collaboration will provide unparalleled opportunities for Allergist and other physician specialties to be part of DFCI’s internationally recognized cancer team.

 Beth Israel Deaconess Medical Center, a 743-bed hospital and Level 1 Trauma Center, is a founding member of Beth Israel Lahey Health (BILH).  BILH, a health care system with 14 hospitals, brings together academic medical centers and teaching hospitals, community and specialty hospitals, and more than 4,000 physicians and 39,000 employees in a shared mission to expand access and advance the science and practice of medicine through groundbreaking research and education.

Harvard Medical Faculty Physicians at Beth Israel Deaconess Medical Center (HMFP) is one of the largest physician organizations in New England, dedicated to excellence and innovation in patient care, education, and research. As a physician-led organization, HMFP partners with more than 2,400 providers